Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 8971059, 9 pages
https://doi.org/10.1155/2017/8971059
Review Article

Influence of Human Papillomavirus Infection on the Natural History of Cervical Intraepithelial Neoplasia 1: A Meta-Analysis

1Department of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, China
2The Key Laboratories for Xinjiang Endemic and Ethnic Diseases, Shihezi University, Shihezi, Xinjiang, China

Correspondence should be addressed to Shugang Li; moc.liamy@gnaguhsil and Mingxia Jing; moc.621@621aixgnimgnij

Received 10 February 2017; Revised 13 April 2017; Accepted 8 May 2017; Published 24 July 2017

Academic Editor: Myong Cheol Lim

Copyright © 2017 Mingzhu Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. H. Gong, The Study of Multi-Monitor Methods on the Natural Prognosis and Intervention Treatment of Cervical Intraepithelial Neoplasiai, Medical School of Nanchang University, Nanchang University, 2007.
  2. X. Xie and W. L. Gou, Obstetrics and Gynecology. 8 version, People's Health Publishing House, Beijing, China, 2013.
  3. Y. J. Feng, “Cervical intraepithelial neoplasia,” Journal of Practical Oncology, vol. 18, no. 3, pp. 169–171, 2003. View at Google Scholar
  4. X. Rong, L. N. Wu, J. Y. Gao et al., “Study of natural history of cervical intraepithelial neoplasia gradeI,” Progress in Obstetrics and Gynecology, vol. 21, no. 5, pp. 365–368, 2012. View at Google Scholar
  5. R. L. Li and Y. Yang, “Clinical study of cervical HPV infection and the prognosis of cervical intraepithelial neoplasia I,” Health Research, vol. 31, no. 2, pp. 97–99, 2011. View at Google Scholar
  6. H. H. Wang, L. Chen, M. Chen, L. L. Wu, and J. P. Li, “Significance of high risk human papillomavirus monitoring in follow-up of cervical intraepithelial neoplasia?” Maternal and Child Health Care of China, vol. 27, no. 6, pp. 820–822, 2012. View at Google Scholar
  7. M. J. Thrall, D. A. Smith, and D. R. Mody, “Women ≥30 years of age with low grade squamous intraepithelial lesion (LSIL) have low positivity rates when cotested for high-risk human papillomavirus: Should we reconsider HPV triage for LSIL in older women?” Diagnostic Cytopathology, vol. 38, no. 6, pp. 407–412, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. B. Mill, “The natural history of cervical cancer and the implications for screening policy,” in Genevao World Health Organization Geneve. Cervical cancer screening programmes, pp. 6–14, 1992. View at Google Scholar
  9. S. K. Kjaer, “Risk factors for cervical neoplasia in Denmark,” APMIS, vol. 80, pp. 1–41, 1998. View at Publisher · View at Google Scholar
  10. A. Sagasta, P. Castillo, A. Saco et al., “P16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix,” Modern Pathology, vol. 29, no. 1, pp. 51–59, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Veijalainen, S. Tuomisaari, T. Luukkaala, and J. Mäenpää, “High risk HPV testing in the triage of repeat ASC-US and LSIL,” Acta Obstetricia et Gynecologica Scandinavica, vol. 94, no. 9, pp. 931–936, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. X. He, H. C. Tao, S. Z. Wang et al., “An analysis of high-risk human papillomavirus DNA-negative cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a retrospective study,” Journal of Capital Medical University, vol. 36, no. 2, pp. 205–211, 2015. View at Google Scholar
  13. Y. H. Zhou, W. F. Fan, Y. Q. Huang, J. J. Dong, and H. Y. Guo, “Combined detection of high-risk human papillomavirus and telomerase gene amplification in a mild cervical intraepithelial neoplasia shunt management role,” Journal of Xinxiang Medical University, vol. 32, no. 11, pp. 1032–1035, 2015. View at Google Scholar
  14. L. Mou, Y. Hu, Y. Lan, and F. L. Lv, “Correlative research of HPV infection and the disease progression of cervical intraepithelial neoplasia,” Chongqing Medicine, vol. 43, no. 29, pp. 3895-3896, 2014. View at Google Scholar
  15. S. Siriaunkgul, J. Settakorn, K. Sukpan et al., “Population-based cervical cancer screening using high-risk HPV DNA test and liquid-based cytology in northern Thailand,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 16, pp. 6837–6842, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Y. Hu, F. H. Zhao, J. F. Ma et al., “A prospective study on the prognosis of biopsy·confirmed cervical intraepithelial neoplasia grade 1 and the relationship witlI higII-risk human papiliomavirus,” Chinese Journal of Preventive Medicine, vol. 48, no. 5, pp. 361–365, 2014. View at Google Scholar
  17. H. Jiang, “The impact of high-risk HPV infection and follow-up on the prognosis of CINI,” International Journal of Gynecology & Obstetrics, vol. 40, no. 4, pp. 324–326, 2013. View at Google Scholar
  18. M. Waldstrøm, R. K. Christensen, and D. Ornskov, “Evaluation of p16INK4a/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion,” Cancer Cytopathology, vol. 121, no. 3, pp. 136–145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. H. A. Katki, M. Schiffman, P. E. Castle et al., “Five-year risks of CIN 3+ and cervical cancer among women who test pap-negative but are HPV-positive,” Journal of Lower Genital Tract Disease, vol. 17, no. 5, supplement 1, pp. S56–S63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. S. W. Byun, A. Lee, S. Kim, Y. J. Choi, Y. S. Lee, and J. S. Park, “Immunostaining of p16INK4a/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases,” International Journal of Medical Sciences, vol. 10, no. 12, pp. 1602–1607, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. G.-D. Liao, J. W. Sellors, H.-K. Sun et al., “P16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China,” International Journal of Cancer, vol. 134, no. 7, pp. 1715–1724, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Li, W. Jiang, S. Y. Zeng, and L. Y. Li, “Prospective study of human telomerase ribonucleic acid component gene detection by fluorescence in situ hybridization in predicting natural prognosis of cervical intraepithelial neoplasia 1,” Chinese Journal of Clinical Oncology, vol. 40, no. 1, pp. 25–28, 2013. View at Google Scholar
  23. L.-W. Huang, Y.-H. Lin, H.-S. Pan, K.-M. Seow, and C.-Y. Lin, “Human papillomavirus genotyping as a predictor of high-grade cervical dysplasia in women with mildly cytologic abnormalities: a two-year follow-up report,” Diagnostic Cytopathology, vol. 40, no. 8, pp. 673–677, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Bowring, R. Albrow, A. Fisher et al., “A prospective study of human papillomavirus (HPV) testing to resolve uncertainty in colposcopy,” Cytopathology, vol. 24, no. 5, pp. 309–313, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Jakobsson, J. Tarkkanen, E. Auvinen, R. Häkkinen, P. Laurila, and A. M. Tapper, “Colposcopy referral rate can be reduced by high-risk human papillomavirus triage in the management of recurrent atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion cytology in Finland,” International Journal of STD and AIDS, vol. 23, no. 7, pp. 485–489, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Ozaki, Y. Zen, and M. Inoue, “Biomarker expression in cervical intraepithelial neoplasia: Potential progression predictive factors for low-grade lesions,” Human Pathology, vol. 42, no. 7, pp. 1007–1012, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Gonzalez-Bosquet, L. Selva, and J. Sabria, “Predictive factors for the detection of CINII-III in the follow-up of women with CIN I,” European Journal of Gynaecological Oncology, vol. 31, no. 4, pp. 369–71, 2010. View at Google Scholar
  28. M. Waldstrøm and D. Ømskov, “Clinical performance of a human papillomavirus messenger RNA test (Aptima HPV Assay)on residual material from archived 3-year-old PreservCyt samples with low-grade squamous intraepithelial lesion,” Archives of Pathology and Laboratory Medicine, vol. 135, no. 8, pp. 1052–1056, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Heider, R. M. Austin, and C. Zhao, “HPV test results stratify risk for histopathologic follow-up findings of high-grade cervical intra-epithelial neoplasia in women with low-grade squamous intra-epithelial lesion pap results,” Acta Cytologica, vol. 55, no. 1, pp. 48–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Cotton, L. Sharp, J. Little et al., “The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial,” BJOG, vol. 117, no. 6, pp. 645–659, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. G. D. Liao, “Prevalence of P161NK4a expression in cervical histology and predictive validity of P161NK4a in cervical intraepithelial neoplasia grade l transformation,” Journal of Chongqing Medical University, 2008. View at Google Scholar
  32. A. Luis Ferreira Santos, S. Françoise Mauricette Derchain, L. Otávio Sarian, M. Roberto Martins, S. Siani Morais, and K. Juhani Syrjänen, “Performance of Pap smear and human papilloma virus testing in the follow-up of women with cervical intraepithelial neoplasia grade 1 managed conservatively,” Acta Obstetricia et Gynecologica Scandinavica, vol. 85, no. 4, pp. 444–450, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Tarkkanen, E. Auvinen, P. Nieminen et al., “HPV DNA testing as an adjunct in the management of patients with low grade cytological lesions in Finland,” Acta Obstetricia et Gynecologica Scandinavica, vol. 86, no. 3, pp. 367–372, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S.-H. Song, J.-K. Lee, M.-J. Oh, J.-Y. Hur, Y.-K. Park, and H.-S. Saw, “Risk factors for the progression or persistence of untreated mild dysplasia of the uterine cervix,” International Journal of Gynecological Cancer, vol. 16, no. 4, pp. 1608–1613, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Clavel, J.-P. Bory, S. Caudroy et al., “Usefulness of HPV testing in the follow-up of untreated cervical low grade lesions,” Histology and Histopathology, vol. 20, no. 4, pp. 1085–1091, 2005. View at Google Scholar · View at Scopus
  36. L. S. Massad, C. T. Evans, H. Minkoff et al., “Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus,” Obstetrics and Gynecology, vol. 104, no. 5, part 1, pp. 1077–1085, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Sastre-Garau, I. Cartier, N. Jourdan-Da Silva, P. De Crémoux, V. Lepage, and D. Charron, “Regression of low-grade cervical intraepithelial neoplasia in patients with HLA-DRB1*13 genotype,” Obstetrics and Gynecology, vol. 104, no. 4, pp. 751–755, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Alameda, P. Fuste, S. Boluda et al., “The Ki-67 labeling index is not a useful predictor for the follow-up of cervical intraepithelial neoplasia 1,” Journal of Lower Genital Tract Disease, vol. 8, no. 4, pp. 313–316, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. N. F. Schlecht, R. W. Platt, E. Duarte-Franco et al., “Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia,” Journal of the National Cancer Institute, vol. 95, no. 17, pp. 1336–1343, 2003. View at Publisher · View at Google Scholar
  40. G. Denise Zielinski, P. J. F. Snijders, L. Rozendaal et al., “High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance,” Journal of Pathology, vol. 195, no. 3, pp. 300–306, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Matsuura, T. Kawagoe, N. Toki, K. Sugihara, and M. Kashimura, “Low grade cervical intraepithelial neoplasia associated with human papillomavirus infection. Long-term follow-up,” Acta Cytologica, vol. 42, no. 3, pp. 625–630, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. R. H. Kaufman, E. Adam, J. Icenogle, and W. C. Reeves, “Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness,” American Journal of Obstetrics and Gynecology, vol. 177, no. 4, pp. 930–936, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. M. J. Campion, J. Cuzick, D. J. McCance, and A. Singer, “Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study,” The Lancet, vol. 328, no. 8501, pp. 237–240, 1986. View at Publisher · View at Google Scholar · View at Scopus
  44. X. T. Zeng, H. Liu, X. Chen, and W. D. Leng, “Meta analysis series IV: quality assessment tool for observational research,” Chinese Journal of Evidence-Based Cardiovascular Medicine, vol. 4, no. 4, pp. 297–299, 2012. View at Google Scholar
  45. ASCUS-LSIL Triage Study (ALTS) Group, “A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations,” American Journal of Obstetrics and Gynecology, vol. 188, no. 6, pp. 1393–1400, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. V. Dalstein, D. Riethmuller, J.-L. Préteti et al., “Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study,” International Journal of Cancer, vol. 106, no. 3, pp. 396–403, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Mendes, I. Bains, T. Vanni, and M. Jit, “Systematic review of model-based cervical screening evaluations,” BMC Cancer, vol. 15, no. 1, article 334, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Sroczynski, P. Schnell-Inderst, N. Mühlberger et al., “Cost-effectiveness of primary HPV screening for cervical cancer in Germany—a decision analysis,” European Journal of Cancer, vol. 47, no. 11, pp. 1633–1646, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. S. J. Goldie, J. J. Kim, and T. C. Wright, “Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more,” Obstetrics and Gynecology, vol. 103, no. 4, pp. 619–631, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. J. J. Kim, M. Brisson, W. J. Edmunds, and S. J. Goldie, “Modeling cervical cancer prevention in developed countries,” Vaccine, vol. 26, supplement 10, pp. K76–K86, 2008. View at Publisher · View at Google Scholar · View at Scopus